Capsule Development LLC – Trademark Portfolio

Entity Type: 16

Capsule Development LLC holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 37 (Building & Construction) — 2 filings in this category. The portfolio also extends into Class 36 (Insurance & Financial) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include CAPSULE. The owner is based in Portland, OR.

2415 NE 41st Ave

Portland, OR 97212

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

CAPSULE
CAPSULE
Registered 2018
CAPSULE
CAPSULE
Abandoned 2017

Trademark Classifications

Capsule Development LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

37
Building & Construction (2 filings)

Building construction; repair; installation services

36
Insurance & Financial (2 filings)

Insurance; financial affairs; monetary affairs; real estate affairs

Frequently Asked Questions

How many trademarks does Capsule Development LLC have?

Capsule Development LLC has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 abandoned.

What trademark classes does Capsule Development LLC file in?

Capsule Development LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 37 (Building & Construction), Class 36 (Insurance & Financial). Class 37 covers building construction; repair; installation services.

What are Capsule Development LLC's most well-known trademarks?

Capsule Development LLC's registered trademark portfolio includes well-known marks such as CAPSULE. These are among 1 currently registered trademark in the portfolio.

What is Capsule Development LLC's trademark registration success rate?

Capsule Development LLC has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.